Triple negative breast cancer means that your cancer is not being fueled by any of the three main types of receptors–estrogen, progesterone nor the Her2 protein. Because of this, the cancer won’t respond to certain targeted therapies including hormone therapy or Her2-targeted agents like Herceptin. Chemotherapy is typically the treatment and there are several options.
Triple negative breast cancer is an aggressive form of the disease and if the cancer is advanced, your doctor may also recommend participation in a clinical trial that involves immunotherapy or targeted therapies.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Elizabeth Comen serves as a medical advisor to SurvivorNet. She is a medical oncologist at Memorial Sloan Kettering Cancer Center. Read More
Triple negative breast cancer means that your cancer is not being fueled by any of the three main types of receptors–estrogen, progesterone nor the Her2 protein. Because of this, the cancer won’t respond to certain targeted therapies including hormone therapy or Her2-targeted agents like Herceptin. Chemotherapy is typically the treatment and there are several options.
Triple negative breast cancer is an aggressive form of the disease and if the cancer is advanced, your doctor may also recommend participation in a clinical trial that involves immunotherapy or targeted therapies.
Read More
